These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19827683)

  • 1. [Metabolic abnormalities as a basis for age-dependent diseases and aging? State of the art].
    Tereshina EV
    Adv Gerontol; 2009; 22(1):129-38. PubMed ID: 19827683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
    Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
    Hajer GR; van Haeften TW; Visseren FL
    Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose homeostasis, obesity and diabetes.
    Bano G
    Best Pract Res Clin Obstet Gynaecol; 2013 Oct; 27(5):715-26. PubMed ID: 23510756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.
    DeFronzo RA
    Diabetologia; 2010 Jul; 53(7):1270-87. PubMed ID: 20361178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in young people.
    Poyrazoglu S; Bas F; Darendeliler F
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed.
    D'Adamo E; Santoro N; Caprio S
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):549-63. PubMed ID: 19717004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].
    Benbaibeche H; Haffaf el M; Kacimi G; Oudjit B; Koceir E
    Ann Biol Clin (Paris); 2014; 72(4):463-72. PubMed ID: 25119805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Fat Accumulation Is Independent of Measures of Insulin Sensitivity.
    Muniyappa R; Noureldin R; Ouwerkerk R; Liu EY; Madan R; Abel BS; Mullins K; Walter MF; Skarulis MC; Gharib AM
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3060-8. PubMed ID: 26020762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity.
    Samad F; Badeanlou L; Shah C; Yang G
    Adv Exp Med Biol; 2011; 721():67-86. PubMed ID: 21910083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.
    Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
    J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Lin JM; Yue XJ; Cheng KK; Liu B; Jin YL; Zhang WS; Thomas GN;
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):181-8. PubMed ID: 20039893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.